UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN, E9
CYPRESS Study 0197 Update
Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Agrees to be Acquired
Dr. Áine Miller to Depart as SVP of Development on November 15, 2026
2026 Annual Meeting Results - Directors Elected for Theravance Biopharma
Earnings Release
Other Events
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Q2
Q1
FY 2025
Q3
FY 2024
SC TO-I
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Merger Proxy Statement
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
PREM14A
Amended Tender Offer Statement by Issuer